Company Profile

Zynex, Inc. is a medical technology company specialized in the manufacturing and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring. The Companyâ€™s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Companyâ€™s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.

Employees

1,000

Sector

Advanced Medical Equipment & Technology

More about the company

27/03	Altivera Medical Holdings, LLC acquired Zynex, Inc.	CI
27/03	Zynex, Inc. Secures Term Loan Credit Agreement Finalized	CI
26/03	Zynex, Inc. Emerged from Bankruptcy	CI
21/03	Court confirms Zynex plan of reorganization on March 19, 2026 - SEC filing	RE
19/03	Third Amended Reorganization Plan Approved for Zynex, Inc.	CI
20/02	Zynex Inc says SEC concluded investigation into Zynex, no enforcement action planned	RE
18/02	Zynex Inc resolves federal investigation into business practices	RE
10/02	Notice of Auction Cancellation and Designation of Successful Bidder Filed by Zynex, Inc.	CI
07/02	Third Amended Combined Joint Reorganization Plan and Disclosure Statement Filed by Zynex, Inc.	CI
04/02	Zynex, Inc. Announces New In-Network Provider Status with Humana	CI
02/02	Second Amended Joint Disclosure Statement Conditionally Approved and Combined Hearing of Second Amended Disclosure Statement and Reorganization Plan Approved for Zynex, Inc.	CI
01/02	Second Amended Combined Joint Reorganization Plan and Disclosure Statement Filed by Zynex, Inc.	CI
29/01	First Amended Combined Joint Reorganization Plan and Disclosure Statement Filed by Zynex, Inc.	CI

01/25/01	RBC Capital Adjusts Price Target on Zynex to $2 From $3, Maintains Sector Perform Rating	MT
01/25/01	HC Wainwright Downgrades Zynex to Neutral From Buy	MT
01/25/01	Medtech Zynex's Q2 revenue falls more than expected, names new CEO, suspends forecast	RE
15/25/15	RBC Cuts Price Target on Zynex to $3 From $4, Keeps Sector Perform Rating	MT
30/25/30	RBC Cuts Price Target on Zynex to $4 From $5, Keeps Sector Perform Rating	MT

27/03	ZYXIQ Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026	NE
27/03	ZYXI SHAREHOLDER UPDATE: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements	PR
26/03	ZYXIQ SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026	NE
25/03	Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 21, 2026 in Zynex, Inc. Lawsuit - ZYXIQ	PR
24/03	ZYXI SHAREHOLDER UPDATE: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements	PR

27/22/27	Top 50 Small-caps 2023
21/22/21	Top 50 Small-caps 2023
21/21/21	Los valores del Nasdaq con mayor crecimiento
21/21/21	Les actions du Nasdaq avec la plus forte croissance

1 day	+5.77%
Current year	-56.35%

Zynex, Inc. Share Price

Stocks

ZYXI

US98986M1036

Advanced Medical Equipment & Technology

Chart: Zynex, Inc.

Latest news: Zynex, Inc.

Last Transcript: Zynex, Inc.

Analysts' recommendations: Zynex, Inc.

Press Releases: Zynex, Inc.

News in other languages: Zynex, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Zynex, Inc.

Latest insider transactions

Other Advanced Medical Equipment & Technology

Company Profile

Current year	0.02	0.13
1 year	0.02	2.1
3 years	0.02	13.77
5 years	0.02	17.25
10 years	0.02	27.02

Manager	Title	Age	Since
Steven Dyson CEO	Chief Executive Officer	53	18/08/2025
Vikram Bajaj DFI	Director of Finance/CFO	50	18/08/2025
John Bibb LAW	General Counsel	53	18/08/2025

Director	Title	Age	Since
Vikram Bajaj BRD	Director/Board Member	50	26/03/2026
John Bibb BRD	Director/Board Member	53	26/03/2026

Date	Insider	Type	Main position	Quantity	% Market Cap.
26/03/26	Barry Michaels	Issuer sale	Director	80,001	0.2633%
26/03/26	Michael Cress	Issuer sale	Director	95,000	0.3126%
26/03/26	Joshua Disbrow	Issuer sale	Director	1,02,000	0.3357%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ZYNEX, INC.	+5.77%	-.--%	-	-	16.93L
THERMO FISHER SCIENTIFIC, INC.	-0.40%	-2.34%	+17.82%	+45.91%	25TCr
DANAHER CORPORATION	+0.33%	+0.64%	+3.49%	+12.96%	16TCr
INTUITIVE SURGICAL, INC.	+1.90%	+6.00%	-17.96%	+65.92%	16TCr
BOSTON SCIENTIFIC CORPORATION	-0.70%	+2.93%	-55.38%	-8.86%	6.62TCr
VEEVA SYSTEMS INC.	+0.15%	+4.09%	+10.82%	+65.55%	5.23TCr
SIEMENS HEALTHINEERS AG	+0.24%	+0.99%	-15.19%	-10.88%	5.22TCr
EDWARDS LIFESCIENCES CORPORATION	-1.13%	+2.85%	+16.39%	+28.99%	5.13TCr
AGILENT TECHNOLOGIES, INC.	-0.47%	+0.06%	+17.37%	+58.29%	4.88TCr
WATERS CORPORATION	-0.42%	+3.83%	+27.55%	+77.45%	4.46TCr
Average	+0.53%	+2.26%	+0.54%	+37.26%	9.82TCr
Weighted average by Cap.	+0.14%	+1.50%	+1.37%	+38.41%